Amarin Corporation plc (AMRN) AMR101 approved by the FDA
- MasterCard (MA) Approves $3.5B Buyback; Announces 10-for-1 Split, 83% Dividend Increase
- Autohome (ATHM) IPO Nearly Doubles on Open
- Pre-Open Stock Movers 12/11: (CYTR) (VIMC) (NRF) Higher; (GEVO) (AVNR) (LH) Lower (more...)
- Costco Wholesale (COST) Misses Q1 EPS by 7c; adj.-Comps Up 5%
- Valero Energy Partners LP (VLP) IPO Opens Up Over 20%
Amarin Corporation plc (Nasdaq: AMRN) AMR101 approved by the FDA according to theStreet.com's Adam Feuerstein
You May Also Be Interested In
- Enzo Biochem (ENZ), Flagship Bio Enter Tissue-Based Companion Diagnostics Partnership
- Sanofi's (SNY) Genzyme Granted FDA Priority Review for Cerdelga NDA
- Emergent Bio (EBS) Issues Encouraging Update on TRU-016 Phase 1b in CLL Patients
Create E-mail Alert Related CategoriesFDA, Hot FDA News
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!